Company Encyclopedia
View More
name
Fresh2
FRES.US
Fresh2 Group Limited, a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests using cancer differentiation analysis technology and device to corporations and life insurance companies in the People’s Republic of China. It also offers physical checkup packages, as well as technology services comprising market research, designing, coding, developing, testing, etc. In addition, the company sells genetic testing kits and skin-care products; and owns core technology platforms, as well as engages in technology development and product distribution. Further, it operates an e-commerce platform that connects food suppliers and supermarket operators and restaurant owners.
1.899 T
FRES.USMarket value -Rank by Market Cap -/-

Financial Score

10/01/2026 Update
C
BiotechnologyIndustry
Industry Ranking0/398
Industry medianC
Industry averageD
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreE
    • ROE-264.77%E
    • Profit Margin-733.70%E
    • Gross Margin0.00%E
  • Growth ScoreA
    • Revenue YoY78.46%A
    • Net Profit YoY-4.17%C
    • Total Assets YoY169.43%A
    • Net Assets YoY564.20%A
  • Cash ScoreB
    • Cash Flow Margin-13.63%D
    • OCF YoY78.46%A
  • Operating ScoreE
    • Turnover0.14E
  • Debt ScoreB
    • Gearing Ratio37.12%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --